- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Alex Georgiou is a medical oncology consultant. He specialises in the treatment of lung cancer, mesothelioma, and thymic cancers.
Dr Alex Georgiou is a Consultant Medical Oncologist at Guy's and St Thomas' NHS Hospital in London (GSTT) and King's College Hospitals. Presently, he also serves as the clinical service lead for all Systemic Anti-Cancer Therapies (SACT) at GSTT.
He is the UK chief investigator and principal investigator at GSTT in multiple international clinical trials investigating novel treatments for lung cancer and mesothelioma. He is also an honorary senior lecturer at King's College London (KCL) and leads on academic research at KCL and GSTT aiming to enhance the early diagnosis, treatment, and outcomes for lung cancer patients.
He completed his medical oncology training at the Royal Marsden Hospital (RMH) in London, 2012-2019. During his training he secured competitive Cancer Research UK (CRUK) funding, which supported his successful three-year PhD (2015-2018) at the Institute of Cancer Research (ICR) London. His doctoral research explored the mechanisms of resistance to targeted anti-cancer therapies, earning him a Merit award from the European Society of Medical Oncology Congress (ESMO) in 2018 and a University of London scholarship in 2019.
He has an extensive publication record in oncology and in particular lung cancer and has been invited to speak at both national and international oncology conferences. Additionally, he provides clinical advice to 'EGFR Positive UK', a UK lung cancer charity.
Profile including patient reviews: https://www.doctify.com/uk/specialist/alexandros-georgiou
Publications can be found here: https://www.researchgate.net/profile/Alexandros-Georgiou
Areas of interest
Lung cancer; non-small cell lung cancer; small cell lung cancer; lung adenocarcinoma; mesothelioma; thymoma; thymic malignancies; targeted therapies; immunotherapy; chemotherapy; EGFR; ALK ROS1; KRAS;
Medical secretaries
- HCA- Alexandros Georgiou Office
- Alexandros.Georgiou@hcaconsultant.co.uk